• About Sakar
    • Key Milestones / History
    • Mission, Vision & Values
    • Management Desk
    • Rewards and Recognition
  • Business
    • Facility
    • Exports
    • Research and Development
    • Quality
    • Future Plans
    • Corporate Social responsibility
  • General Product
    • Oral - Liquid Syrup & Suspension
    • Liquid Injectable (SVP)-Vials & Ampoules
    • Cephalosporin - Dry Powder Injections
    • Cephalosporin – Oral Solid
    • Lyophilised Injections (In Vials)
  • Oncology Product
    • Oral Solid Dosage(Tablet & Capsule)
    • Liquid Injection
    • Lyophilised Injection
    • Active Pharmaceutical Ingredient(API)
    • CDMO Products
    • CRAMs
  • Clients
  • Investor Relations
    • Financial Reports (Quarterly & Annually)
      • Quarterly
        • Financial Results
        • Investor Presentation
        • Earnings audio Call Recording
        • Earnings Call transcript
        • Shareholding Pattern (Quarterly)
        • Press Release
        • Earnings call Invite
        • Factsheet (Quarterly/Annually)
      • Annual
        • Annual Reports
      • Subsidiary financials
        • Quarterly
        • Annually
    • Board of Directors
      • Board of Directors and Small description
      • Committees
    • Shareholder’s Information
      • Share price information from BSE & NSE
      • Notices & Intimations
      • Corporate Announcements
      • Shareholder’s Meet / AGM
      • Credit Rating
      • Policies
    • Corporate Governance
      • Corporate Governance
      • Appointment of committee members, Key Managerial positions
      • Documents related to Corporate governance, Compliance
    • Board of Directors
      • Board of Directors and Small description
      • Event Calendar
    • Investor Support
      • Registrar, Company Secretary and Transfer Agent Information
      • Grievance Redressal
      • Reverse Enquiry Toolkit
  • News & Awards
    • Rewards and Recognition
  • Careers
  • Contact

    Financial Results

Financial Results

  • Financial Result as on 31st December, 2022
  • Financial Result as on 30th September, 2022
  • Financial Result as on 30th June, 2022
  • Financial Result as on 31st March 2022
  • Financial Result as on 31st Dec 2021
  • Financial Result as on 30th Sept 2021
  • Financial Result as on 30th June, 2021
  • Financial Result as on 31st March 2021
  • Financial Result as on 31st Dec 2020
  • Financial Result as on 30th Sept 2020
  • Financial Result as on 30th June 2020
  • Financial Result as on 31st March 2020
  • Financial Result as on 31st Dec 2019
  • Financial Result as on 30th June 2019
  • Financial Result as on 30th Sept 2019
  • Financial Result as on 31st March 2019
  • Financial Result as on 30th Sept 2018
  • Financial Results as on 31st March 2018
  • Financial Results as on 30th Sep 2017
  • Financial Results as on 31st March 2017
  • Home
  • Prestigious Clients
  • Careers
  • Gallery
  • Enquiry
  • Contact Us
  • Sitemap
    Profile
  • About Us
  • Vision & mission
  • Exports
  • Future Plans
  • Corporate Social Responsibility
    Strength
  • Quality
  • Research & Development
  • Facility
    Products
  • Oral - Liquid Syrup & Suspension
  • Liquid Injectable (SVP)-Vials & Ampoules - EU GMP Approved
  • Cephalosporin - Dry Powder Injections
  • Cephalosporin – Oral Solid
  • Lyophilised Injections (In Vials) - EU GMP Approved